DurAVR™ THV System: EMBARK Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.
Also called NCT05182307
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose device feasibility
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Anteris Technologies Ltd.
- Registry
-
NCT05182307
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Georgia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05182307. Allocation not applicable; no masking; primary purpose device feasibility. Start 2021-11-15 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DurAVR™ THV System: EMBARK Study
- Condition
- Symptomatic Aortic Stenosis
- Condition
- Severe Aortic Valve Stenosis
- Condition
- Aortic Valve Calcification
- Intervention (Device)
- DurAVR™ THV System
- Lead sponsor
- Anteris Technologies Ltd.
Record details
- Record id
cardio:ct-nct05182307- Content hash
2bd01320c656c6c4b7846aa4d1bb4d7477680225ba65c4f02fc6dbce5abedd79